Johnson & Johnson (JNJ) EVP reports stock awards, option grants and tax share withholdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Johnson & Johnson executive Kathryn E. Wengel, EVP and Chief TO and Risk Officer, reported multiple equity compensation transactions. She exercised vested restricted share units and performance share units into common stock on February 13 and 15, 2026, and received new grants of restricted share units and employee stock options under the company’s Long-Term Incentive Plan.
On those dates she acquired common shares through derivative exercises and awards, while a portion of the resulting shares was withheld at prices of $243.45 and $244.55 per share to cover tax obligations, which is disclosed as share dispositions. After these transactions, she held 113,977.8735 common shares directly, plus additional indirect holdings in the Johnson & Johnson Savings Plan and ESOP.
Positive
- None.
Negative
- None.
Insider Trade Summary
15,598 shares exercised/converted
Mixed
16 txns
Insider
Wengel Kathryn E
Role
EVP, Chief TO and Risk Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Share Units | 606 | $0.00 | -- |
| Exercise | Restricted Share Units | 635 | $0.00 | -- |
| Grant/Award | Employee Stock Options (Right to Buy) | 16,945 | $0.00 | -- |
| Grant/Award | Restricted Share Units | 1,217 | $0.00 | -- |
| Exercise | Common Stock | 606 | $0.00 | -- |
| Tax Withholding | Common Stock | 310 | $243.45 | $75K |
| Exercise | Common Stock | 635 | $0.00 | -- |
| Tax Withholding | Common Stock | 325 | $243.45 | $79K |
| Exercise | Restricted Share Units | 651 | $0.00 | -- |
| Exercise | Performance Share Units | 13,706 | $0.00 | -- |
| Exercise | Common Stock | 651 | $0.00 | -- |
| Tax Withholding | Common Stock | 217 | $244.55 | $53K |
| Exercise | Common Stock | 13,706 | $0.00 | -- |
| Tax Withholding | Common Stock | 6,414 | $244.55 | $1.57M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Share Units — 606 shares (Direct);
Employee Stock Options (Right to Buy) — 16,945 shares (Direct);
Common Stock — 114,287.874 shares (Direct);
Performance Share Units — 0 shares (Direct);
Common Stock — 86 shares (Indirect, By 401k)
Footnotes (1)
- Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Shares withheld for payment of taxes upon vesting of RSUs. Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. Shares withheld for payment of taxes upon vesting of PSUs. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026). Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026). Each RSU represents a contingent right to receive one share of Company Common Stock. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
FAQ
What did Johnson & Johnson (JNJ) executive Kathryn Wengel report in this Form 4?
Kathryn Wengel reported equity compensation activity, including exercises of vested restricted and performance share units into common stock and new grants of restricted share units and stock options. Some shares were withheld to pay taxes, a common feature of long-term incentive plans.
Did Kathryn Wengel buy or sell Johnson & Johnson (JNJ) stock in the open market?
The filing shows no open-market buys or sells. Shares described as dispositions were withheld by Johnson & Johnson at set prices to cover tax obligations upon vesting and conversion of equity awards, rather than discretionary sales on the market.
What new equity awards did Kathryn Wengel receive from Johnson & Johnson (JNJ)?
She received 16,945 employee stock options and 1,217 restricted share units, all granted under Johnson & Johnson’s Long-Term Incentive Plan. These awards vest in three equal annual installments beginning on the first anniversary of the February 15, 2026 grant date.
How were taxes handled on Kathryn Wengel’s Johnson & Johnson (JNJ) equity vesting?
When her restricted share units and performance share units vested and converted into common stock, Johnson & Johnson withheld 6,414 and smaller blocks of shares at prices around $243–$245. These withheld shares satisfied tax obligations instead of a cash payment.
What is the vesting structure of Kathryn Wengel’s Johnson & Johnson (JNJ) RSUs and options?
Restricted share units and stock options granted on various February dates vest in three equal annual installments starting one year after grant. Upon vesting, each RSU converts into one share of Johnson & Johnson common stock, creating a staged long-term compensation schedule.